Company / Cost of Revenue
Medtronic Cost of Revenue History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$11.2B
FY2026
5-year range
$9.4B / $11.6B
FY2022-FY2026
Trend
+4.6%
vs FY2025
Sector context
#11 of 113
Health Care
What the data says
Among 113 Health Care companies, Medtronic is in the bottom 10% for cost of revenue. Cost of Revenue has fluctuated over the past 10 years, ranging from $9.1B in FY2017 to $11.6B in FY2024.
Based on SEC 10-K filings.
$11.2B in FY2026 with a 5-year CAGR of +4.1%. Top quartile in the Health Care sector.
Improved from $11.6B to $11.2B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +4.1%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 90% of 113This company $11.2B Sector average $11.3B
▼
In line with sector average
Key checks
Key Insights
- 5-year CAGR of +4.1%, indicating consistent growth.
- In FY2026, cost of revenue increased 4.6% year-over-year.
- Ranks #11 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $11.2B | +4.6% |
| FY2025 | $10.7B | -7.8% |
| FY2024 | $11.6B | +11.0% |
| FY2023 | $10.5B | +11.2% |
| FY2022 | $9.4B | +2.9% |
| FY2021 | $9.2B | -12.7% |
| FY2020 | $10.5B | +11.2% |
| FY2019 | $9.4B | +2.9% |
| FY2018 | $9.2B | +1.0% |
| FY2017 | $9.1B | -2.4% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026